Page 15 of 17
Bioconjugate Chemistry
1
2
3
Hum. Gene Ther. 26, 475ꢀ485.
(10) Lennox, K. A., and Behlke, M. A. (2011) Chemical modification and design of antiꢀmiRNA
oligonucleotides. Gene Ther. 18, 1111ꢀ1120.
(11) Deleavey, G. F., and Damha, M. J. (2012) Designing chemically modified oligonucleotides for targeted
gene silencing. Chem. Biol. 19, 937ꢀ954.
(12) Zheng, J., Yang, R. H., Shi, M. L., Wu, C. C., Fang, X. H., Li, Y. H., Li, J. H., and Tan, W. H. (2015)
Rationally designed molecular beacons for bioanalytical and biomedical applications. Chem. Soc. Rev. 44,
3036ꢀ3055.
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(13) Ozcan, G., Ozpolat, B., Coleman, R. L., Sood, A. K., and LopezꢀBerestein, G. (2015) Preclinical and
clinical development of siRNAꢀbased therapeutics. Adv. Drug Deliv. Rev. 87, 108ꢀ119.
(14) Singh, S. K., Kumar, R., and Wengel, J. (1998) Synthesis of 2 'ꢀaminoꢀLNA: A novel conformationally
restricted highꢀaffinity oligonucleotide analogue with a handle. J. Org. Chem. 63, 10035ꢀ10039.
(15) Campbell, M. A., and Wengel, J. (2011) Locked vs. unlocked nucleic acids (LNAvs.UNA): contrasting
structures work towards common therapeutic goals. Chem. Soc. Rev. 40, 5680ꢀ5689.
(16) Astakhova, I. K., and Wengel, J. (2014) Scaffolding along nucleic acid duplexes using 2'ꢀaminoꢀlocked
nucleic acids. Acc. Chem. Res. 47, 1768ꢀ1777.
(17) Hojland, T., Kumar, S., Babu, B. R., Umemoto, T., Albaek, N., Sharma, P. K., Nielsena, P., and Wengel, J.
(2007) LNA (locked nucleic acid) and analogs as triplexꢀforming oligonucleotides. Org. Biomol. Chem. 5,
2375ꢀ2379.
(18) Noir, R., Kotera, M., Pons, B., Remy, J. S., and Behr, J. P. (2008) Oligonucleotideꢀoligospermine
conjugates (zip nucleic acids): a convenient means of finely tuning hybridization temperatures. J. Am.
Chem. Soc. 130, 13500ꢀ13505.
(19) Winkler, J., Saadat, K., DiazꢀGavilan, M., Urban, E., and Noe, C. R. (2009) Oligonucleotideꢀpolyamine
conjugates: influence of length and position of 2'ꢀattached polyamines on duplex stability and antisense
effect. Eur. J. Med. Chem. 44, 670ꢀ677.
(20) Astakhova, I. K., Hansen, L. H., Vester, B., and Wengel, J. (2013) PeptideꢀLNA oligonucleotide conjugates.
Org. Biomol. Chem. 11, 4240ꢀ4249.
(21) Shrestha, A. R., Kotobuki, Y., Hari, Y., and Obika, S. (2014) Guanidine bridged nucleic acid (GuNA): an
effect of a cationic bridged nucleic acid on DNA binding affinity. Chem. Commun. 50, 575ꢀ577.
(22) Lou, C., Vester, B., and Wengel, J. (2015) Oligonucleotides containing a piperazinoꢀmodified 2'ꢀaminoꢀ
LNA monomer exhibit very high duplex stability and remarkable nuclease resistance. Chem. Commun. 51,
4024ꢀ4027.
(23) Boisguerin, P., Deshayes, S., Gait, M. J., O'Donovan, L., Godfrey, C., Betts, C. A., Wood, M. J. A., and
Lebleu, B. (2015) Delivery of therapeutic oligonucleotides with cell penetrating peptides. Adv. Drug Deliv.
Rev. 87, 52ꢀ67.
(24) Menzi, M., Lightfoot, H. L., and Hall, J. (2015) Polyamineꢀoligonucleotide conjugates: a promising
direction for nucleic acid tools and therapeutics. Future Med. Chem. 7, 1733ꢀ1749.
(25) Gagnon, K. T., Watts, J. K., Pendergraff, H. M., Montaillier, C., Thai, D., Potier, P., and Corey, D. R. (2011)
Antisense and antigene inhibition of gene expression by cellꢀpermeable oligonucleotideꢀoligospermine
conjugates. J. Am. Chem. Soc. 133, 8404ꢀ8407.
(26) Paris, C., Moreau, V., Deglane, G., Karim, L., Couturier, B., Bonnet, M. E., Kedinger, V., Messmer, M.,
BolcatoꢀBellemin, A. L., Behr, J. P., Erbacher, P., and LenneꢀSamuel, N. (2012) Conjugating
phosphospermines to siRNAs for improved stability in serum, intracellular delivery and RNAiꢀmediated
gene silencing. Mol. Pharm. 9, 3464ꢀ3475.
(27) Geny, S., Moreno, Pedro M. D., Krzywkowski, T., Gissberg, O., Andersen, N. K., Isse, A. J., ElꢀMadani, A.
M., Lou, C., Pabon, Y. V., Anderson, B. A., Zaghloul, E. M., Zain, R., Hrdlicka, P. J., Jørgensen, P. T.,
Nilsson, M., Lundin, K. E., Pedersen, E. B., Wengel, J., and Smith, C. I. E. (2016) Nextꢀgeneration bisꢀ
locked nucleic acids with stacking linker and 2′ꢀglycylaminoꢀLNA show enhanced DNA invasion into
supercoiled duplexes. Nucleic Acids Res. 44, 2007ꢀ2019.
(28) Bottcher, T., KolodkinꢀGal, I., Kolter, R., Losick, R., and Clardy, J. (2013) Synthesis and activity of
biomimetic biofilm disruptors. J. Am. Chem. Soc. 135, 2927ꢀ2930.
(29) Madsen, A. S., Jorgensen, A. S., Jensen, T. B., and Wengel, J. (2012) Large scale synthesis of 2'ꢀaminoꢀ
LNA thymine and 5ꢀmethylcytosine nucleosides. J. Org. Chem. 77, 10718ꢀ10728.
(30) Hujakka, H., Ratilainen, J., Korjamo, T., Lankinen, H., Kuusela, P., Santa, H., Laatikainen, R., and
Narvanen, A. (2001) Synthesis and antimicrobial activity of the symmetric dimeric form of temporin a
based on 3ꢀN,Nꢀdi(3ꢀaminopropyl)amino propanoic acid as the branching unit. Bioorg. Med. Chem. 9,
1601ꢀ1607.
(31) Paredes, E., Evans, M., and Das, S. R. (2011) RNA labeling, conjugation and ligation. Methods 54, 251ꢀ
259.
(32) Shelbourne, M., ElꢀSagheer, A. H., and Brown, T. (2012) Fast and efficient DNA crosslinking and multiple
orthogonal labelling by copperꢀfree click chemistry. Chem. Commun. 48, 11184ꢀ11186.
ACS Paragon Plus Environment